Monica Ramello
Ospedale Maggiore · 27 works · 354 citations · h-index 9
Top works
- Fatigue: A main component of anemia symptomatology
- Fertility concerns, preservation strategies and quality of life in young women with breast cancer: Baseline results from an ongoing prospective cohort study in selected European Centers
- Clinical Outcomes and Safety of Patients Treated with NAb-Paclitaxel Plus Gemcitabine in Metastatic Pancreatic Cancer: The NAPA Study
- Risk Factors for Nab-Paclitaxel and Gemcitabine-Induced Peripheral Neuropathy in Patients with Pancreatic Cancer
- Capecitabine as a Second-line Treatment for Older Patients with Pancreatic Cancer
- Diagnostic accuracy of perforated compression grid approach for mammographically guided core needle biopsy of breast lesions
- Association between neutropenia and survival to nab-paclitaxel and gemcitabine in patients with metastatic pancreatic cancer
- Association between Low-Grade Chemotherapy-Induced Peripheral Neuropathy (CINP) and Survival in Patients with Metastatic Adenocarcinoma of the Pancreas
- FOLFOX vs FOLFIRI as Second-line of Therapy After Progression to Gemcitabine/Nab-paclitaxel in Patients with Metastatic Pancreatic Cancer
- The value of patient centred care in oncology
- Prognostic Value of Alkaline Phosphatase and Gamma-Glutamyl Transferase in Patients with Metastatic Pancreatic Cancer
- “Understanding older patients: Communication as the key step for a comprehensive approach”
- The impact of age, performance status and comorbidities on nab-paclitaxel plus gemcitabine effectiveness in patients with metastatic pancreatic cancer
- Information given to cancer patients on diagnosis, prognosis and treatment: the clinical oncologist's perspective
- Prognostic role of sodium levels in colorectal cancer patients receiving aflibercept plus FOLFIRI
- Surgical oncology in the elderly
- ONC-2012-001: A single-arm phase II study of tivantinib (ARQ 197) plus cetuximab in EGFR inhibitor-resistant MET high patients (pts) with locally advanced or metastatic colorectal cancer (CRC) with wild-type KRAS.
- Endpoints of medical treatment of colorectal cancer.
- Prospective evaluation of liposomal doxorubicin (LD) in patients (pts) with metastatic breast cancer (MBC) pretreated with conventional anthracyclines
- Clinical outcome and safety profile of metastatic pancreatic cancer patients treated with more than six cycles of nab-paclitaxel plus gemcitabine